ANAVEX LIFE SCIENCES CORP. cotiza a 1.48 USD y tiene una capitalización bursátil de $137M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and v…
| Periodo | 2026-11 | 2026-08 | 2026-07 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.08 | $-0.06 | $-0.06 |
| Estimado | $-0.11 | $-0.08 | $-0.07 | $-0.11 |
| Sorpresa | — | +200.0% | +14.3% | +45.5% |
| Métrica | AVXL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -48.9% | -40.4% | -8.5% |
| ROA | -44.7% | -32.0% | -12.7% |
| Current Ratio | — | 2.84 | — |
| Debt / Equity | — | 0.28 | — |